BioPharmaTrend
Latest News
All Topics
  • Artificial Intelligence
  • NeuroTech
  • Premium Content
  • Knowledge Center
Interviews
Companies
  • Company Directory
  • Sponsored Case Studies
  • Create Company Profile
More
  • About Us
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
  • Write for Us
Subscribe
Login/Join
back to Directory

Phenomic AI

Phenomic AI logo

Website
https://phenomic.ai/
Founded
2017
Patents
5
Publications
4

Technologies

AI Companies (Drug Discovery)

Phenomic AI is accelerating drug discovery with AI.

Our founding team consists of PhDs who pioneered the application of deep learning to biological imaging screens and chemo-informatics. The combination of machine learning technologies and phenotypic screening (a holistic approach to drug discovery) has the potential to unlock key discoveries that will greatly advance medicine in the next decade. Phenomic AI is leading this revolution in drug discovery.


Posts Mentioning This Company

Technology Meets Biology in Canada

Oct. 11, 2022  
Over the past decade, Canada emerged as a promising global location for drug discovery and biotech business, especially when it comes to applying advanced technologies, such as artificial intelligence (AI) and quantum computing in life sciences.
Toronto Startups Develop AI for Drug Discovery

Toronto’s Blossoming AI-driven Drug Discovery Scene

Aug. 2, 2022  
Canada has established itself as a rapidly growing global hub for artificial intelligence (AI) innovation and commercialization. This roots deep into the history of early programs and funding provided by Canadian Institute for Advanced Research (CIFAR) and the Natural Sciences and Engineering Research Council of Canada (NSERC) to such AI …
#advertisement
ThermoFisher Scientific: Integrated genetic technologies for cell therapy development
#advertisement
Webinar: AI in Clinical Trials

 

R&D Platform

Phenomic predicts which cells will survive chemotherapy and identifies compounds that selectively target these resistant cells. It will then develop the compounds and bring them to market. The prediction requires the use of cell imaging technology, which is where the AI comes in.

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
gnews  Google News
rss  RSS Feed

About


  • What we do
  • Citations and Press Coverage
  • Terms of Use
  • Privacy Policy
  • Disclaimer

We Offer


  • Premium Content
  • BioTech Scout
  • Interviews
  • Partner Events
  • Case Studies

Opportunities


  • Membership
  • Advertise
  • Submit Company
  • Write for Us
  • Contact Us

© BPT Analytics LTD 2025
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.